14/03/2024
Updates from the European Medicines Agency (EMA) shed light on the recent revision of the QRD Templates, particularly tailored to comply with QRD template v10.4 updated on 29/02/2024, addressing the regulatory implications post-Br
17/01/2024
Happy New Year 2024! As we step into this bright new year, all of us at AxeRegel extend our warmest wishes to our valued partners, clients, and the entire healthcare community.2023 was a remarkable year, filled with challenge
18/10/2023
Hello, fellow healthcare enthusiasts and pharmaceutical professionals! The European Medicines Agency (EMA) has just dropped a new set of answers in their post-authorisation procedural advice! If you're not already in the
21/09/2023
Let’s dive into something that's reshaping the landscape of the pharmaceutical industry: Big Data.Big Data isn't just a trend; it's a revolution. Imagine vast amounts of data from clinical trials, patient records, genomi
22/06/2023
On 26 April 2023, the European Commission presented its project to revise the EU's pharmaceutical legislation. This revision, which is part of the Pharmaceutical Strategy for Europe presented by the European Commission in November